A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
| Status: | Completed |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any - 21 |
| Updated: | 4/21/2016 |
| Start Date: | March 1996 |
| End Date: | January 2008 |
Study Hypothesis: Clinical staging without laparotomy/splenectomy is adequate for children
and young adults with Hodgkin's disease who receive chemotherapy as a component of
treatment.
and young adults with Hodgkin's disease who receive chemotherapy as a component of
treatment.
- Age less than 21 years at diagnosis
- Previously untreated, pathologically confirmed diagnosis of Hodgkin's disease.
- Informed patient/parental consent as required by individual institution and in
accordance with the Dept of Health and Human Services
- Approval of this protocol by the individual institutional Human Subjects Review
Committee.
- Indicate Hodgkin's disease clinical stage.
- Indicate presence or absence of "B" symptoms.
- For Stage I and II disease indicate the following:
- presence or absence of bulk disease
- number of involved nodal regions
- presence or absence of hilar adenopathy
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
